I TNG S DNG: Vin ung nga nm Dr Lacir dnh cho N gii trng thnh c nhu cu lm p da, ph n suy gim chc nng sinh l, ph n tin mn kinh, mn kinh do cc biu hin do suy gim ni tit t n nh: au u, chng mt, bc ha, nm da, kh da, sm da
sitagliptin Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)
It is worth highlighting that BPC-157s relation with nerve growth factor 1-A binding protein-2 may exert inhibitory action on specific elements
Always follow up with sunscreen during the daytime to protect your new glow
It does not appear toxic, does not accumulate in tissues, and has been well tolerated in trials
